What happens when you take estrogen with dong quai?
Dong quai (Angelica sinensis) is a root used in traditional Chinese medicine for menstrual and menopausal symptoms. Prescribed estrogen is taken to reach a specific, measured level of hormonal activity. When the two overlap, here is what the laboratory evidence suggests happens.
- Dong quai behaves like estrogen in tissue. In cell studies it has shown estrogen-agonist activity, meaning it can switch on estrogen receptors the way estrogen itself does.
- It can stimulate hormone-sensitive cells. A water extract of dong quai increased proliferation of estrogen receptor-positive (MCF-7) breast cancer cells, with or without added estrogen present.
- That signal adds to your prescribed estrogen. Layered on top of an estrogen product that is already dosed to a target, dong quai introduces a second estrogenic input that no one is measuring.
- It can also nudge bleeding risk. Dong quai contains coumarin compounds. A published case report described a woman whose blood-thinning effect from warfarin rose after she started dong quai, then normalized once she stopped it.
Most of this evidence is preclinical (cell and animal studies) plus a single case report. There is no human study of dong quai combined with prescribed estrogen, so the concern is a precautionary one rather than a proven clinical harm.
Why is this important?
Estrogen therapy, whether prescribed for menopausal symptoms, for contraception, or as part of gender-affirming care, is chosen to reach specific tissue exposures. Adding an herbal product with its own estrogen-like activity introduces an additional, unmeasured signal in tissues that are already being targeted, including breast and endometrium.
For people with a personal or family history of breast, endometrial, or ovarian cancer, or uterine fibroids, the concern is sharper. Memorial Sloan Kettering's guidance is that patients with hormone-sensitive cancers should consult their physicians before using this herb, and many integrative oncologists advise avoidance because of the estrogen-agonist signal seen in tissue and animal models.
The bleeding angle matters too. Estrogen therapy and dong quai can each shift clotting and bleeding risk through different mechanisms, and the net effect in any one person is hard to predict, especially for someone already on warfarin, a direct oral anticoagulant, or daily aspirin.
What should you do?
Do not start dong quai while taking prescribed estrogen, and do not start estrogen while taking dong quai, without first discussing it with the clinician who manages your hormone therapy. A simple way to keep the two apart:
- Before a change in therapy: If you have been using dong quai and are about to start hormone therapy, stop the herb first and allow time for it to clear before beginning the prescription. Build that gap into your timeline rather than overlapping the two. Your clinician can advise how long to wait.
- Every day while on estrogen, a SERM, or the contraceptive pill: Do not add dong quai, including the multi-herb menopause blends that often contain it. Read labels on "women's health" or "menopause support" formulas, since dong quai is frequently included without being prominently advertised.
- After any change: If you are on an anticoagulant and have been taking dong quai, do not stop it abruptly without telling your clinician, because your bleeding or clotting risk may shift. If you have a history of hormone-sensitive cancer, avoid dong quai entirely and ask about non-estrogenic options for symptom relief.
If you are using dong quai for hot flashes, vaginal dryness, or other menopausal symptoms, ask your clinician about evidence-based alternatives that do not stimulate hormone-sensitive tissue, such as vaginal estrogen for genitourinary symptoms, certain prescription medicines for vasomotor symptoms, or cognitive behavioral therapy.
Which specific products are affected?
The concern applies to all forms of prescribed estrogen, including oral estradiol and conjugated estrogens (Premarin), transdermal patches and gels (Climara, Vivelle-Dot, Divigel, EstroGel), vaginal estrogen products (Estring, Vagifem, Imvexxy, even though systemic absorption is low), and combined oral contraceptives. It also applies to selective estrogen receptor modulators (raloxifene, tamoxifen, bazedoxifene), which act on the same receptors dong quai may stimulate. The concern is the estrogenic signal itself, not any particular dose form.
On the dong quai side, it appears as standalone capsules and as a component of menopausal symptom blends marketed under names such as Estroven and Remifemin Plus, and in various "women's balance" or "menopause support" formulas. It also appears in traditional Chinese herbal decoctions where it is often combined with peony, ligusticum, and rehmannia. Treat all of these the same way.
Anticoagulants and daily aspirin (warfarin, apixaban, rivaroxaban, edoxaban, dabigatran, aspirin) are a separate reason to avoid dong quai, because of additive bleeding risk.
The science behind it
The estrogen-agonist signal comes from cell and animal work. Lau and colleagues (2005) reported that dong quai stimulated proliferation of estrogen receptor-positive (MCF-7) and receptor-negative (BT-20) breast cancer cells in vitro, and questioned whether the herb is appropriate for women with breast cancer (PMID 16278617). Zhu and colleagues (2021) found that Angelica sinensis promoted growth of estrogen receptor-positive breast cancer in both cell and mouse-xenograft models, acting through estrogen-receptor-driven pathways (PMID 34271113). Memorial Sloan Kettering Cancer Center's integrative medicine herb monograph summarizes these findings and advises patients with hormone-sensitive cancers to consult their physicians before use.
The bleeding signal rests on a single case report: Page and Lawrence (1999) described potentiation of warfarin's anticoagulant effect in a woman who had started dong quai (PMID 10417036). This is one report, not a controlled study, so it supports caution rather than a firm conclusion.
Frequently Asked Questions
Is dong quai proven to be dangerous with estrogen in people?
No. The estrogen-agonist evidence comes from cell and animal studies, and the bleeding evidence is a single case report. There is no human study of dong quai combined with prescribed estrogen. The advice to avoid the combination is precautionary.
I take a birth control pill. Does this apply to me?
Combined oral contraceptives contain estrogen, so the same caution applies. Talk to your clinician or pharmacist before adding dong quai or a menopause blend that contains it.
What if I have a history of breast cancer?
Avoiding dong quai is the cautious choice. The herb has stimulated estrogen receptor-positive breast cancer cells in the lab, and integrative oncology guidance steers people with hormone-sensitive cancers away from it. Discuss any herbal product with your oncology team.
I already take both. What should I do?
Do not panic, and do not stop anything abruptly if you are on an anticoagulant. Tell the clinician who manages your hormone therapy at your next contact so the two can be reviewed together.
Are there safer options for menopausal symptoms?
Yes. Depending on your symptoms, options that do not add an estrogenic signal include vaginal estrogen for genitourinary symptoms, certain prescription medicines for hot flashes, and cognitive behavioral therapy. Your clinician can match these to your situation.
How long should I wait between stopping dong quai and starting estrogen?
Plan a gap rather than overlapping the two, and let your clinician advise the timing based on your situation. The goal is to avoid running both estrogenic signals at once.
Key takeaways
- Dong quai shows estrogen-agonist activity and can stimulate estrogen receptor-positive breast cancer cells in cell and animal studies.
- Evidence is preclinical plus one warfarin case report, so this is a precautionary caution, not a proven clinical harm.
- Avoid combining dong quai with prescribed estrogen, a SERM, or the contraceptive pill, and avoid it entirely with a history of hormone-sensitive cancer.
- Dong quai can add to bleeding risk, so avoid it if you take an anticoagulant or daily aspirin.
- It often hides in multi-herb menopause blends, so read labels and review any herbal product with your doctor or pharmacist first.